Search results
The Unexpected Reason Gilead Just Notched Its Biggest Single-Day Move In A Month
Investor's Business Daily· 9 months agoInvestors don't fully appreciate Gilead Sciences' leadership in HIV treatment, an analyst said...
Gilead (GILD) Outpaces Industry in Six Months: What Lies Ahead?
Zacks via Yahoo Finance· 2 years agoShares of Gilead Sciences, Inc. GILD have gained 3.7% in the last six months against the industry’s...
Gilead profit tops expectations despite lower COVID drug sales, outlook raised
Reuters via Yahoo Finance· 2 years agoGilead Sciences Inc on Thursday posted a higher-than-expected third-quarter profit on the back of...
Gilead Sciences, Inc. (NASDAQ:GILD) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 months agoGilead Sciences, Inc. (NASDAQ:GILD) Q4 2023 Earnings Call Transcript February 6, 2024 Gilead...
Gilead (GILD) Up 2.6% in 3 Months: Will the Momentum Continue?
Zacks via Yahoo Finance· 2 years agoShares of Gilead Sciences, Inc. GILD has gained 2.6% in the past three months against the industry’s...
Gilead (GILD) Gets FDA Nod for Twice-Yearly HIV Treatment
Zacks via Yahoo Finance· 1 year agoGilead'ls (GILD) HIV franchise gets a boost with FDA's approval of twice-yearly HIV treatment...
Gilead (GILD) Announces Positive New Data on Breast Cancer Drug
Zacks via Yahoo Finance· 2 years agoGilead Sciences, Inc. GILD has announced positive new data from a post hoc subgroup analysis from...
Gilead (GILD) Gets EC Approval for Biktarvy Label Expansion
Zacks via Yahoo Finance· 2 years agoGilead Sciences, Inc. GILD announced that the European Commission (EC) has authorized a new low-dose...
The Zacks Analyst Blog Highlights Regeneron Pharmaceuticals, Gilead Sciences, Novavax, Apellis...
Zacks via Yahoo Finance· 10 months agoFor Immediate Release Chicago, IL – August 25, 2023 – Zacks.com announces the list of stocks...
Gilead (GILD) to Report Q4 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 1 year agoInvestors' focus is likely to be on Gilead's (GILD) HIV franchise performance and oncology sales...